Antidepressants may not improve likelihood of completing HCV treatment

11/22/2013 | Healio (free registration)

Authors of a review found giving hepatitis C patients prophylactic antidepressants did not increase compliance with interferon-based treatment regimens. University of Texas researchers said depression may affect as many as 30% of HCV patients, but while antidepressants were associated with reduced symptoms, they did not lead to better treatment completion rates.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI